RBC Capital Mkts resumed coverage on ICON plc with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for ICLR
Across the 17 sessions after earlier ICLR headlines, the stock closed higher 9 times and lower 7 times, with a median move of 3.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ICLR | SPY |
|---|---|---|---|
| May 13, 2026 | ICON expands US early phase research capabilities with new clinic and outpatient centres | -3.7% | +0.6% |
| May 5, 2026 | HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem | +8.4% | +0.8% |
| Apr 29, 2026 | ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results | +13.3% | -0.0% |
| Mar 26, 2026 | ICON plc upgraded by BMO Capital Markets with a new price target | +3.1% | -1.8% |
| Mar 24, 2026 | ICON and Advarra Introduce New 'Research-Ready,' Connected Site Network Model | +0.9% | -0.3% |
| Feb 23, 2026 | ICON plc upgraded by Jefferies with a new price target | +5.0% | -1.0% |
Keep researching ICLR
Quantisnow market dataNASDAQ
ICLR
ICON plc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Listed since
- 1998
Get push alerts for ICLR
Full ICLR profile on Quantisnow Follow ICLR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time